Drug Type Small molecule drug |
Synonyms JSM8757 |
Target |
Mechanism α5β1 antagonists(Integrin alpha-5/beta-1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | DE | 01 Jun 2009 |